Back to Search Start Over

Assays to Study Consequences of Cytoplasmic Intermediate Filament Mutations: The Case of Epidermal Keratins.

Authors :
Tan TS
Ng YZ
Badowski C
Dang T
Common JE
Lacina L
Szeverényi I
Lane EB
Source :
Methods in enzymology [Methods Enzymol] 2016; Vol. 568, pp. 219-53. Date of Electronic Publication: 2016 Jan 06.
Publication Year :
2016

Abstract

The discovery of the causative link between keratin mutations and a growing number of human diseases opened the way for a better understanding of the function of the whole intermediate filament families of cytoskeleton proteins. This chapter describes analytical approaches to identification and interpretation of the consequences of keratin mutations, from the clinical and diagnostic level to cells in tissue culture. Intermediate filament pathologies can be accurately diagnosed from skin biopsies and DNA samples. The Human Intermediate Filament Database collates reported mutations in intermediate filament genes and their diseases, and can help clinicians to establish accurate diagnoses, leading to disease stratification for genetic counseling, optimal care delivery, and future mutation-aligned new therapies. Looking at the best-studied keratinopathy, epidermolysis bullosa simplex, the generation of cell lines mimicking keratinopathies is described, in which tagged mutant keratins facilitate live-cell imaging to make use of today's powerful enhanced light microscopy modalities. Cell stress assays such as cell spreading and cell migration in scratch wound assays can interrogate the consequences of the compromised cytoskeletal network. Application of extrinsic stresses, such as heat, osmotic, or mechanical stress, can enhance the differentiation of mutant keratin cells from wild-type cells. To bring the experiments to the next level, 3D organotypic human cultures can be generated, and even grafted onto the backs of immunodeficient mice for greater in vivo relevance. While development of these assays has focused on mutant K5/K14 cells, the approaches are often applicable to mutations in other intermediate filaments, reinforcing fundamental commonalities in spite of diverse clinical pathologies.<br /> (Copyright © 2016 Tong San Tan, Yi Zhen Ng, Cedric Badowski, Tram Dang, John E.A. Common, Lukas Lacina, Ildikó Szeverényi, and E. Birgitte Lane. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1557-7988
Volume :
568
Database :
MEDLINE
Journal :
Methods in enzymology
Publication Type :
Academic Journal
Accession number :
26795473
Full Text :
https://doi.org/10.1016/bs.mie.2015.09.030